Biomanufacturing

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Understand microbial control in biotherapy production

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharmaceuticals #GMP #Microbiology #QA/QC #Webinar

Implementing rapid microbial identification in biotherapy manufacturing

Join DDW for this free on-demand event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. It is presented by Phil Tuckett, BS, RM(NRCM, Department Scientist, Nelson Laboratories and Michelle Thai, Technical Sales Specialist, Pharma… Read More

Webinar date:
Brought to you by Thermo Fisher Scientific
#Webinars

Bacteria
#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Microbial identification in biotherapy manufacturing

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Enhancing quality control in biotherapy manufacturing

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharma #Cancer therapeutics #Drug discovery #Immutep #LAG-3

New podcast: Important therapies for the future of immunotherapy

This is the latest episode of the free DDW narrated podcast, “Important therapies for the future of immunotherapy”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Improving quality control for CAR T cell therapies”, and… Read More

#News

Cell engineering
#Automation #biological engineering #Biomanufacturing #Biopharmaceuticals #Biosecurity #Cell programming

Ginkgo Bioworks expands its R&D facilities 

Boston-based Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has launched Bioworks7, the latest expansion of its biological engineering foundry.   With this new space, Ginkgo’s increased capacity will serve partners in cell and gene therapy, biomanufacturing and general mammalian programming for therapeutic applications and new biopharmaceutical… Read More

#Business & Investment #News

GenScript facility
#Biomanufacturing #Cell and gene therapy #Expansion #GenScript #Manufacturing

GenScript expands capacity for cell and gene therapy programmes

GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies.  The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials. The company’s… Read More

#News

#Biomanufacturing #Cell and Gene Therapy Catapult #Cell therapy #Manufacturing

UK consortium looks to advance cell therapy manufacturing  

A new consortium has been launched in the UK to help drive innovation in the manufacturing of personalised cell therapies.  The consortium was launched by the Cell and Gene Therapy Catapult (CGT Catapult) and will be led by advanced therapy medicinal products (ATMP) developer Achilles Therapeutics. The… Read More

#News

#Biomanufacturing #Cell and gene therapy #Manufacturing

Collaboration aims to advance cell and gene therapy manufacturing  

A collaboration between a medical technology company and a non-profit group is aiming to advance the supply chain for cell and gene manufacturing in a bid to tackle scale-up and quality challenges within the sector.  Terumo Blood and Cell Technologies will work with GenCure to extend and… Read More

#News

#Biomanufacturing #CDMO

Matica Biotechnology expands viral vector capacity  

Contract development and manufacturing organisation (CMDO) Matica Biotechnology has opened a new facility for the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.  Through the facility, Matica Bio is expanding its capacity as a CDMO… Read More

#News

#Biomanufacturing #Biosciences #Biotherapeutics #Drug development #Therapeutics

Partnership to develop and manufacture biosimilars

Abzena and BioXpress Therapeutics have partnered to support biosimilar development for third party customers, creating an integrated solution between two service providers with expertise in biosimilar development and GMP manufacture. The partnership will ensure biosimilar drug developers benefit from an integrated approach to biosimilars spanning the range from design consultancy,… Read More

#News

#Biomanufacturing #Corning Life Sciences #Drug discovery #Immunology / Virology & Vaccines #Life sciences #SARS-CoV-2

Optimising vaccine production through customisation

Listen to this article on the DDW Podcast: An expert’s view by John Yoshi Shyu, Ph.D. Corning Life Sciences. Most vaccines are manufactured using technology devised fifty or more years ago, in manufacturing plants that are sometimes even older. The vaccine production process is continually refreshed by new tools and technologies,… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News

#Biomanufacturing #Life sciences #Recruitment

Recruitment: Director of The Stack Family CBET

Albany College of Pharmacy and Health Sciences has an opening for the Director of The Stack Family Centre for Biopharmaceutical Education and Training (CBET). CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. The CBET Director will be responsible for the development and creation of sustainable… Read More

#News

#Biologics / Biotechnology #Biomanufacturing #Cell therapy #Drug development

Cedars-Sinai biomanufacturing centre spurs cell therapies to help develop new drugs

Cedars-Sinai has launched a centre to manufacture the next generation of stem cell and gene therapies that will enable biomedical researchers, government medical programs, commercial entities and others to develop new biologic drugs and propel novel disease discoveries. Biologic drugs are produced from living organisms or contain components of living… Read More

#Editor's Choice #News